265 related articles for article (PubMed ID: 31281528)
1. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
[TBL] [Abstract][Full Text] [Related]
3. Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
Hong Y; Peng Y; Guo ZS; Guevara-Patino J; Pang J; Butterfield LH; Mivechi NF; Munn DH; Bartlett DL; He Y
Hepatology; 2014 Apr; 59(4):1448-58. PubMed ID: 24122861
[TBL] [Abstract][Full Text] [Related]
4. Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.
Liu Y; Butterfield LH; Fu X; Song Z; Zhang X; Lu C; Ding G; Wu M
Int J Oncol; 2011 Jul; 39(1):245-53. PubMed ID: 21491085
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
6. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
Zuo B; Qi H; Lu Z; Chen L; Sun B; Yang R; Zhang Y; Liu Z; Gao X; You A; Wu L; Jing R; Zhou Q; Yin H
Nat Commun; 2020 Apr; 11(1):1790. PubMed ID: 32286296
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein 96 and α-fetoprotein cross-linking complexes elicited specific antitumor immunity.
Wang XP; Wang QX; Lin HP; Wang YL; Yang Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):406-14. PubMed ID: 23484810
[TBL] [Abstract][Full Text] [Related]
9. Specific antitumor immunity induced by cross-linking complex heat shock protein 72 and alpha-fetoprotein.
Wang XP; Lin HP; Wang QX; Gu Y
Cancer Biother Radiopharm; 2012 Apr; 27(3):189-97. PubMed ID: 22372558
[TBL] [Abstract][Full Text] [Related]
10. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.
Zuo B; Zhang Y; Zhao K; Wu L; Qi H; Yang R; Gao X; Geng M; Wu Y; Jing R; Zhou Q; Seow Y; Yin H
J Hematol Oncol; 2022 Apr; 15(1):46. PubMed ID: 35488312
[TBL] [Abstract][Full Text] [Related]
11. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
12. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
13. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Wang X; Wang Q
Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966
[TBL] [Abstract][Full Text] [Related]
14. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine.
Bei R; Mizejewski GJ
Curr Mol Med; 2011 Oct; 11(7):564-81. PubMed ID: 21707514
[TBL] [Abstract][Full Text] [Related]
15.
Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C
Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
Clin Exp Med; 2018 Nov; 18(4):535-546. PubMed ID: 30062618
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
Palmer DH; Midgley RS; Mirza N; Torr EE; Ahmed F; Steele JC; Steven NM; Kerr DJ; Young LS; Adams DH
Hepatology; 2009 Jan; 49(1):124-32. PubMed ID: 18980227
[TBL] [Abstract][Full Text] [Related]
18. Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70.
Wang XP; Liu GZ; Song AL; Li HY; Liu Y
World J Gastroenterol; 2004 Nov; 10(21):3197-200. PubMed ID: 15457574
[TBL] [Abstract][Full Text] [Related]
19. Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide.
Long J; Zhou B; Li H; Dai Q; Zhang B; Xing S; Zeng Z; Chen W; Yang J
Immunol Invest; 2013; 42(2):137-55. PubMed ID: 23323523
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
Pang XH; Chen MS; Jia WH; Zhou XX
Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
